Protocol No: ECCT/26/06/01 Date of Protocol: 09-06-2026

Study Title:

antimalaria2

Study Objectives:

To evaluate the safety and effectiveness of a new antimalarial drug in treating uncomplicated malaria.

Laymans Summary:

Malaria remains a major health challenge in many countries. This study aims to evaluate a new treatment for malaria and compare it with the current standard treatment. Adults diagnosed with uncomplicated malaria will be invited to participate and will be randomly assigned to receive either the new treatment or the standard treatment. 

Abstract of Study:

Malaria continues to be a significant public health concern, particularly in regions where the disease is endemic. New treatment options are needed to improve patient outcomes and address emerging drug resistance.